Literature DB >> 10873680

The structure of the human LIM protein ACT gene and its expression in tumor cell lines.

M J Morgan1, S A Whawell.   

Abstract

We describe the human ACT genomic and cDNA sequence which like its murine counterpart contains the defining secondary structure of the FHL (Four-and-a-Half LIM-domain) LIM-protein family. The coding region of the human ACT gene spans five exons. This distribution is very similar to the FHL1 gene and includes the arrangement of split codons across exon boundaries suggesting that these genes share a common ancestor. The human ACT gene was not detected by Northern analysis in the adult testis although this is the only known site of expression found with its murine counterpart. However, the human ACT gene was found to be expressed in a panel of human tumor cell lines derived from squamous cell carcinomas, melanomas, and leukemias. Interestingly, FHL1, FHL2, and FHL3 were also found to be expressed in some of these cell lines and the results suggest an important role for FHLs in tumor biology. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873680     DOI: 10.1006/bbrc.2000.3006

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.

Authors:  Yuanhong Xu; Zhe Liu; Kejian Guo
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

2.  Negative control of keratinocyte differentiation by Rho/CRIK signaling coupled with up-regulation of KyoT1/2 (FHL1) expression.

Authors:  Maddalena Grossi; Agnès Hiou-Feige; Alice Tommasi Di Vignano; Enzo Calautti; Paola Ostano; Sam Lee; Giovanna Chiorino; G Paolo Dotto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

3.  FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.

Authors:  Shuting Bai; Hideki Kitaura; Haibo Zhao; Ju Chen; Judith M Müller; Roland Schüle; Bryant Darnay; Deborah V Novack; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

4.  Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.

Authors:  Parveen Sharma; Thiruchelvi Shathasivam; Vladimir Ignatchenko; Thomas Kislinger; Anthony O Gramolini
Journal:  Mol Biosyst       Date:  2011-01-18

5.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

6.  c-Abl kinase regulates cell proliferation and ionizing radiation-induced G2/M arrest via phosphorylation of FHL2.

Authors:  Guang-Fei Wang; Xiayang Niu; Hainan Liu; Qincai Dong; Yebao Yao; Di Wang; Xuan Liu; Cheng Cao
Journal:  FEBS Open Bio       Date:  2021-05-19       Impact factor: 2.693

Review 7.  Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.

Authors:  Thiruchelvi Shathasivam; Thomas Kislinger; Anthony O Gramolini
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

8.  FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.

Authors:  Wei Fu; Kai Wang; Jun-Long Zhao; Heng-Chao Yu; San-Zhong Li; Yan Lin; Liang Liang; Si-Yong Huang; Ying-Min Liang; Hua Han; Hong-Yan Qin
Journal:  BMC Cancer       Date:  2014-06-22       Impact factor: 4.430

9.  KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.

Authors:  Qingqing Yan; Wenjing Zhang; Yao Wu; Meiyan Wu; Mengnan Zhang; Xinpeng Shi; Jinjun Zhao; Qingzhen Nan; Ye Chen; Long Wang; Tianming Cheng; Jiachu Li; Yang Bai; Side Liu; Jide Wang
Journal:  Oncotarget       Date:  2015-09-22

10.  Identification and characterization of MT-1X as a novel FHL3-binding partner.

Authors:  Xin Cai; Jinfeng Wang; Xin Huang; Wenliang Fu; Wenrong Xia; Minji Zou; Yuanyuan Wang; Jiaxi Wang; Donggang Xu
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.